MAM
Mudra Max appoints Sonia Lal as vice president South- OOH
MUMBAI: Mudra Max, a part of the Mudra Group, has appointed Sonia Lal as the vice president for its outdoor division- South India.
Prior to this appointment, Lal was with the Bangalore based company Serve & Volley- Media Division as business head.
Says Mudra Max-OOH Mandeep Malhotra president, “Sonia brings on board business experience and market understanding. She also carries the confidence of media owners which is essential for this business. Her passion and well understanding of business makes her a strong OOH person at Mudra Max.”
Adds Lal, “It‘s an honor as well as a challenge to be part of the Mudra team. I keenly look forward to work with the Group and I am certain that as we move along, we will greatly strengthen our capabilities in outdoor solutions.”
In her career spanning over 12 years, Lal has worked for seven years with IDBI Bank and three years with a mid-sized steel fabrication company.
Some of the notable clients that Lal has worked with include Arvind Brands Retail business -Megamart and TVS Motors. She has also played a crucial role during the launch of Tata Tea‘s fruit and tea based health drink in South India.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
